Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic

Giuseppe Curigliano; Maria Joao Cardoso; Philip Poortmans; Oreste Gentilini; Gabriella Pravettoni; Ketti Mazzocco; Nehmat Houssami; Olivia Pagani; Elzbieta Senkus; Fatima Cardoso

Breast (Aug 2020)

Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic

Giuseppe Curigliano,
Maria Joao Cardoso,
Philip Poortmans,
Oreste Gentilini,
Gabriella Pravettoni,
Ketti Mazzocco,
Nehmat Houssami,
Olivia Pagani,
Elzbieta Senkus,
Fatima Cardoso

Affiliations

Giuseppe Curigliano: Istituto Europeo di Oncologia, IRCCS, Department of Early Drug Development, Italy; University of Milano, Milano, Italy; Corresponding author. Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, University of Milan, Department of Oncology and Haemato-Oncology, Via Giuseppe Ripamonti n. 435, 20141, Milan, Italy.
Maria Joao Cardoso: Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, Portugal; Nova Medical School, Lisbon, Portugal
Philip Poortmans: Iridium Kankernetwerk, Department of Radiation Oncology, Wilrijk-Antwerp, Belgium; University of Antwerp, Faculty of Medicine and Health Sciences, Wilrijk-Antwerp, Belgium
Oreste Gentilini: Breast Surgery, San Raffaele University and Research Hospital, Milano, Italy
Gabriella Pravettoni: Istituto Europeo di Oncologia, IRCCS, Department of Early Drug Development, Italy; University of Milano, Milano, Italy
Ketti Mazzocco: Istituto Europeo di Oncologia, IRCCS, Department of Early Drug Development, Italy; University of Milano, Milano, Italy
Nehmat Houssami: Faculty of Medicine and Health, Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia
Olivia Pagani: Service Interdisciplinaire de Cancérologie, Hopital Riviera-Chablais, Rennaz, Vaud, Geneva University Hospitals, Swiss Group for Clinical Cancer Research (SAKK), Switzerland
Elzbieta Senkus: Medical University of Gdansk, Gdansk, Poland
Fatima Cardoso: Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, Portugal

Journal volume & issue: Vol. 52
pp. 8 – 16

Abstract

Read online

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) associated disease (COVID-19) outbreak seriously challenges globally all health care systems and professionals. Expert projections estimate that despite social distancing and lockdown being practiced, we have yet to feel the full impact of COVID-19. In this manuscript we provide guidance to prepare for the impact of COVID-19 pandemic on breast cancer patients and advise on how to triage, prioritize and organize diagnostic procedures, surgical, radiation and medical treatments.

Published in Breast

ISSN: 1532-3080 (Online)
Publisher: Elsevier
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://www.journals.elsevier.com/the-breast

About the journal